Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Biolog-id

Explore full profile

Identification technology to manage and trace sensitive health products

Boulogne-Billancourt, FranceFounded 2005Health Tech & Medtech
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Biolog-id and the history behind them.

About Biolog-id

Biolog-id was founded with a vision to transform the way healthcare logistics are managed. The company was established by a team of innovators who recognized the inefficiencies in the management of sensitive healthcare products like blood, plasma, and other biologics. Although specific names of the founders are not readily available, their mission was clear: to enhance safety, efficiency, and traceability in healthcare logistics.

Biolog-id developed a proprietary RFID-based solution that allows for real-time tracking and management of these critical products. This technology ensures that healthcare providers can maintain the integrity and safety of their supplies, ultimately improving patient outcomes.

A significant milestone in Biolog-id's journey was securing major funding to expand its operations and technology. This financial boost enabled the company to scale its solutions globally, partnering with healthcare institutions across various continents.

Biolog-id's impact on the healthcare industry is profound, providing a level of transparency and efficiency previously unattainable. Their solutions not only reduce waste and cost but also enhance the overall safety of healthcare logistics. Today, Biolog-id continues to innovate, driven by a commitment to improving healthcare systems worldwide.

Source: Dealroom company data

At a glance

Founded
2005
Headquarters
Boulogne-Billancourt, France
Sector
Health Tech & Medtech
Power Law
Colt$25–100M revenue

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Xerys
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
8 countries with
team presence
🇫🇷 France73.9%
🇺🇸 United States13%
🇵🇹 Portugal2.2%
🇪🇸 Spain2.2%
🇮🇹 Italy2.2%
Top 5 of 8 shown
Web traffic by country
1K monthly visits
across markets
🇺🇸 United States70%
🇵🇭 Philippines20%
🇵🇱 Poland0%
🇹🇷 Turkey0%
Top 4 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Biolog-id on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Biolog-id on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.